2seventy bio, Inc. (TSVT) Tops Q1 EPS by 18c

2seventy bio, Inc. (NASDAQ: TSVT) reported Q1 EPS of $0.01, $0.18 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $22.94 million versus the consensus estimate of $13.96 million.

For earnings history and earnings-related data on 2seventy bio, Inc. (TSVT) click here.

You May Also Be Interested In

• Tesla readies August launch of CyberCab - The Information
• Western Digital (WDC) call put ratio 1 call to 1.2 puts on 57K contracts
• Sandisk (SNDK) call put ratio 1.1 calls to 1 put on active option volume of 300K contracts as share price up 7.5%